Becton Dickinson and Co (NYSE:BDX)

256.43
Delayed Data
As of May 27
 +3.93 / +1.56%
Today’s Change
229.24
Today|||52-Week Range
277.29
+4.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$71.9B

Company Description

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Contact Information

Becton, Dickinson & Co.
1 Becton Drive
Franklin Lakes New Jersey 07417-1880
P:(201) 847-6800
Investor Relations:

Employees

Shareholders

Mutual fund holders52.12%
Other institutional38.31%
Individual stakeholders0.76%

Top Executives

Thomas E. PolenChairman, President & Chief Executive Officer
Christopher J. DelOreficeChief Financial Officer & Executive Vice President
William R. SigmundChief Medical Officer & Executive Vice President
Elizabeth McCombsChief Technology Officer & Executive VP
Colleen RileyChief Technology Officer & Senior Vice President